Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine epidural gelfoam versus paravertebral intramuscular injection for postoperative analgesia after lumbar spine surgery
IRCT20230520058233N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Pain severity, Time to first request for analgesic medication and 1 more. Started Aug 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20230520058233N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230520058233N1.